Evidence map›Paper›PMID 21994750›Full record

ReviewViruses2011

The role of interferon antagonist, non-structural proteins in the pathogenesis and emergence of arboviruses.

Bradley S Hollidge, Susan R Weiss, Samantha S Soldan

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Frontiers in cellular and infection microbiology · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in microbiology · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bradley S HollidgeDepartment of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. hollidge@mail.med.upenn.edu
Susan R Weiss
Samantha S Soldan
University of Pennsylvania · US

Funding

TRAINING IN NEUROVIROLOGY AND NEUROIMMUNOLOGYT32NS007180 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 1985 to 2018
$2.8M
Characterization of the La Crosse Virus glycoprotein fusion peptideR01AI074626 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SOLDAN, SAMANTHA STANDISH · 2008 to 2012
$1.7M
Neurovirulence of murine coronavirus: roles of viral genesR01NS054695 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 2006 to 2010
$1.7M
NIAID NIH HHS R01 AI074626NINDS NIH HHS NS-054695NINDS NIH HHS NS-074626NINDS NIH HHS R01 NS054695NINDS NIH HHS T32 NS007180NINDS NIH HHS T32-NS07180
6 · The paper itself

Abstract

A myriad of factors favor the emergence and re-emergence of arthropod-borne viruses (arboviruses), including migration, climate change, intensified livestock production, an increasing volume of international trade and transportation, and changes to ecosystems (e.g., deforestation and loss of biodiversity). Consequently, arboviruses are distributed worldwide and represent over 30% of all emerging infectious diseases identified in the past decade. Although some arboviral infections go undetected or are associated with mild, flu-like symptoms, many are important human and veterinary pathogens causing serious illnesses such as arthritis, gastroenteritis, encephalitis and hemorrhagic fever and devastating economic loss as a consequence of lost productivity and high mortality rates among livestock. One of the most consistent molecular features of emerging arboviruses, in addition to their near exclusive use of RNA genomes, is the inclusion of viral, non-structural proteins that act as interferon antagonists. In this review, we describe these interferon antagonists and common strategies that arboviruses use to counter the host innate immune response. In addition, we discuss the complex interplay between host factors and viral determinants that are associated with virus emergence and re-emergence, and identify potential targets for vaccine and anti-viral therapies.

Indexed as

AnimalsArbovirusesArbovirus InfectionsHumansInterferonsViral Nonstructural ProteinsInterferonsViral Nonstructural Proteinsalphavirusarbovirusbunyavirusemergenceflavivirusinnate immune systeminterferon

Identifiers

PMID21994750
PMCPMC3185780
OpenAlexW2082416483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.